Bayer settles glyphosate claims for up to $10.9 billion

摘要

Bayer has announced a series of agreements to resolve legacy Monsanto litigation, including a payment of $10.1–10.9 billion (€9.1–9.8 billion) to address current and future claims alleging that glyphosate, a widely used herbicide frst introduced by Monsanto in 1974, causes cancer. Funded from free cash fow and the recent divestiture of Bayer’s animal health business, Bayer says the settlement brings closure to about 75% of the current Roundup litigation—involving approximately 125,000 fled and unfled claims overall—for $8.8–9.6 billion, which also includes an allowance expected to cover plaintifs with whom the company has not yet reached an agreement. Bayer inherited the Roundup liability with its $63-billion takeover of Monsanto in June 2018.